缺血性脑卒中的血液学生物标志物研究进展

doi:10.3969/j.issn.1003-9198.2024.12.021

摘要/Abstract

摘要： 随着我国老龄化社会的进展,缺血性脑卒中(ischemic stroke,IS)患病率呈逐年增长的趋势。IS的早期诊断、及时治疗是老年IS病人获得较好预后及生活质量的关键。研究表明,血清学生物标志物对IS的早期诊断、治疗以及预后预测具有重要意义,本研究就IS发病过程中的病因、诊断、治疗、预后预测全过程的血清学生物标志物的研究进展作一综述,以指导临床实践。

中图分类号:

R 743.33

廖彪, 冯美江. 缺血性脑卒中的血液学生物标志物研究进展[J]. 实用老年医学, 2024, 38(12): 1284-1287.

[1] FEIGIN V L, BRAININ M, NORRVING B, et al. World Stroke Organization (WSO): Global Stroke Fact Sheet 2022[J]. Int J Stroke, 2022, 17(1): 18-29.
[2] FAN L S, CHEN Y C, LIAO R J, et al. Antagonism of histamine H₃ receptor promotes angiogenesis following focal cerebral ischemia[J]. Acta Pharmacol Sin, 2022, 43(11): 2807-2816.
[3] POWERS W J, RABINSTEIN A A, ACKERSON T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J]. Stroke, 2019, 50(12):344-418.
[4] MITAKI S, WADA Y, SHEIKH A M, et al. Proteomic analysis of extracellular vesicles enriched serum associated with future ischemic stroke[J]. Sci Rep, 2021, 11(1): 24024.
[5] PARK K Y, AY I, AVERY R, et al. New biomarker for acute ischaemic stroke: plasma glycogen phosphorylase isoenzyme BB[J]. J Neurol Neurosurg Psychiatry, 2018, 89(4): 404-409.
[6] KWEON O J, LIM Y K, LEE M K, et al. Clinical utility of serum holotranscobalamin measurements in patients with first-ever ischemic stroke[J]. Dis Markers, 2021, 2021:9914298.
[7] TIEDT S, BRANDMAIER S, KOLLMEIER H, et al. Circulating metabolites differentiate acute ischemic stroke from stroke mimics[J]. Ann Neurol, 2020, 88(4): 736-746.
[8] FAN H, YANG S, LI Y, et al. Assessment of homocysteine as a diagnostic and early prognostic biomarker for patients with acute lacunar infarction[J]. Eur Neurol, 2018, 79(1/2): 54-62.
[9] EBIHARA K, YAMAGISHI K, UMESAWA M, et al. Moderate levels of N-terminal pro-B-type natriuretic peptide is associated with increased risks of total and ischemic strokes among Japanese: the circulatory risk in communities study[J]. J Atheroscler Thromb, 2020, 27(8): 751-760.
[10] WEISS R, BUSHI D, MINDEL E, et al. Autoantibodies to annexin A2 and cerebral thrombosis: insights from a mouse model[J]. Lupus, 2021, 30(5): 775-784.
[11] WANG J, ZHAO H, FAN Z, et al. Long noncoding RNA H19 promotes neuroinflammation in ischemic stroke by driving histone deacetylase 1-dependent M1 microglial polarization[J]. Stroke, 2017, 48(8): 2211-2221.
[12] REZAEI M, MOKHTARI M J, BAYAT M, et al. Long non-coding RNA H19 expression and functional polymorphism rs217727 are linked to increased ischemic stroke risk[J]. BMC Neurol, 2021, 21(1): 54.
[13] WANG J, RUAN J, ZHU M, et al. Predictive value of long noncoding RNA ZFAS1 in patients with ischemic stroke[J]. Clin Exp Hypertens, 2019, 41(7): 615-621.
[14] SIMATS A, RAMIRO L, GARCÍA-BERROCOSO T, et al. A mouse brain-based multi-omics integrative approach reveals potential blood biomarkers for ischemic stroke[J]. Mol Cell Proteomics, 2020, 19(12): 1921-1936.
[15] BUSTAMANTE A, LÓPEZ-CANCIO E, PICH S, et al. Blood biomarkers for the early diagnosis of stroke: the stroke-chip study[J].Stroke, 2017, 48(9):2419-2425.
[16] LI L, DONG L, ZHAO J, et al. Circulating miRNA-3552 as a potential biomarker for ischemic stroke in rats[J]. Biomed Res Int, 2020, 2020:4501393.
[17] HOLMEGAARD L, STANNE T M, ANDREASSON U, et al. Proinflammatory protein signatures in cryptogenic and large artery atherosclerosis stroke[J]. Acta Neurol Scand, 2021, 143(3): 303-312.
[18] SINGLETON M J, YUAN Y, DAWOOD F Z, et al. Multiple blood biomarkers and stroke risk in atrial fibrillation: the REGARDS study[J]. J Am Heart Assoc, 2021, 10(15): e020157.
[19] ZHANG M, WANG Y, WEI J, et al. BNP combined with echocardiographic parameters to predict the risk of cardioembolic stroke[J]. J Clin Neurosci, 2021, 88: 213-218.
[20] HARPAZ D, BAJPAI R, NG G J L, et al. Blood biomarkers to detect new-onset atrial fibrillation and cardioembolism in ischemic stroke patients[J]. Heart Rhythm, 2021, 18(6): 855-861.
[21] MODAK J M, ROY-O’REILLY M, ZHU L, et al. Differential microribonucleic acid expression in cardioembolic stroke[J]. J Stroke Cerebrovasc Dis, 2019, 28(1):121-124.
[22] ZHU Z, TANG W, GE L, et al. The value of plasma fibrillin-1 level in patients with spontaneous cerebral artery dissection[J]. Neurology, 2018, 90(9):e732-e737.
[23] ROZANSKI M, AUDEBERT H J. Glial fibrillary acidic protein in acute stroke: what we know and what we need to know[J]. AME Med J, 2018, 3: 14.
[24] STAMOVA B, ANDER B P, JICKLING G, et al. The intracerebral hemorrhage blood transcriptome in humans differs from the ischemic stroke and vascular risk factor control blood transcriptomes[J]. J Cereb Blood Flow Metab, 2019, 39(9): 1818-1835.
[25] THIEBAUT A M, GAUBERTI M, ALI C, et al. The role of plasminogen activators in stroke treatment: fibrinolysis and beyond[J]. Lancet Neurol, 2018, 17(12): 1121-1132.
[26] BUSTAMANTE A, NING M, GARCÍA-BERROCOSO T, et al. Usefulness of ADAMTS13 to predict response to recanalization therapies in acute ischemic stroke[J]. Neurology, 2018, 90(12):e995-e1004.
[27] ZANG N, LIN Z, HUANG K, et al. Biomarkers of unfavorable outcome in acute ischemic stroke patients with successful recanalization by endovascular thrombectomy[J]. Cerebrovasc Dis, 2020, 49(6): 583-592.
[28] SHI K, ZOU M, JIA D M, et al. tPA mobilizes immune cells that exacerbate hemorrhagic transformation in stroke[J]. Circ Res, 2021, 128(1): 62-75.
[29] KAZMIERSKI R, MICHALAK S, WENCEL-WAROT A, et al. Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients[J]. Neurology, 2012, 79(16): 1677-1685.
[30] PENG Q, HOU J, WANG S, et al. Hypersensitive C-reactive protein-albumin ratio predicts symptomatic intracranial hemorrhage after endovascular therapy in acute ischemic stroke patients[J]. BMC Neurol, 2021, 21(1): 47.
[31] JICKLING G C, ANDER B P, STAMOVA B, et al. RNA in blood is altered prior to hemorrhagic transformation in ischemic stroke[J]. Ann Neurol, 2013, 74(2): 232-240.
[32] ZHANG Y, MA T, HU H, et al. Serum vascular endothelial growth factor as a biomarker for prognosis of minor ischemic stroke[J]. Clin Neurol Neurosurg, 2020, 196:106060.
[33] HU Z, YANG X, HUANG R, et al. Association of circulating ICAM3 concentrations with severity and short-term outcomes of acute ischemic stroke[J]. Neurotox Res, 2021, 39(4): 1293-1299.
[34] CUADRADO-GODIA E, OIS A, GARCIA-RAMALLO E, et al. Biomarkers to predict clinical progression in small vessel disease strokes: prognostic role of albuminuria and oxidized LDL cholesterol[J]. Atherosclerosis, 2011, 219(1): 368-372.
[35] GONG P, LIU Y, HUANG T, et al. The association between high-sensitivity C-reactive protein at admission and progressive motor deficits in patients with penetrating artery infarctions[J]. BMC Neurol, 2019, 19(1): 346.
[36] SUN J, LV X, GAO X, et al. The association between serum uric acid level and the risk of cognitive impairment after ischemic stroke[J]. Neurosci Lett, 2020, 734:135098.
[37] WANG Q, WANG K, MA Y, et al. Serum galectin-3 as a potential predictive biomarker is associated with poststroke cognitive impairment[J]. Oxid Med Cell Longev, 2021, 2021:5827812.
[38] YANG C D, CHENG M L, LIU W, et al. Association of serum retinoic acid with depression in patients with acute ischemic stroke[J]. Aging: Albany NY, 2020, 12(3): 2647-2658.
[39] YU S, LUO Y, ZHANG T, et al. Eosinophil-to-monocyte ratio is a potential biomarker in the prediction of functional outcome among patients with acute ischemic stroke[J]. BMC Neurosci, 2021, 22(1): 8.
[40] WALL A, ANGER O, JOOD K, et al. Circulating granulocyte colony-stimulating factor and functional outcome after ischemic stroke: an observational study[J]. Neurol Res, 2021, 43(12): 1013-1022.
[41] SCHWEDHELM E, SCHWIEREN L, TIEDT S, et al. Serum sphingosine-1-phosphate levels are associated with severity and outcome in patients with cerebral ischemia[J]. Stroke, 2021, 52(12): 3901-3907.
[42] XU Y, WANG K, WANG Q, et al. The antioxidant enzyme PON1: a potential prognostic predictor of acute ischemic stroke[J]. Oxid Med Cell Longev, 2021, 2021:6677111.
[43] GUO D, ZHU Z, ZHONG C, et al. Prognostic metrics associated with inflammation and atherosclerosis signaling evaluate the burden of adverse clinical outcomes in ischemic stroke patients[J]. Clin Chem, 2020, 66(11): 1434-1443.
[44] MA J, SHEN L, BAO L, et al. A novel prognosis prediction model, including cytotoxic T lymphocyte-associated antigen-4, ischemia-modified albumin, lipoprotein-associated phospholipase A2, glial fibrillary acidic protein, and homocysteine, for ischemic stroke in the Chinese hypertensive population[J]. J Clin Lab Anal, 2021, 35(5): 317-322.

缺血性脑卒中的血液学生物标志物研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

推荐阅读 10

[1]	陈吐芬, 张波. 50例老年戊型肝炎临床特点与血清学特征分析[J]. 实用老年医学, 2024, 38(7): 722-726.
[2]	杨绍孔, 陈立文, 沈华, 张铮. 脓毒症心肌病诊断及预后标志物的研究进展[J]. 实用老年医学, 2024, 38(7): 748-752.
[3]	张丽莉, 李静, 丁林锋, 孙静娴, 蔡静波. 颈动脉粥样硬化斑块对非瓣膜性心房颤动病人缺血性脑卒中事件的预测价值[J]. 实用老年医学, 2024, 38(3): 236-239.
[4]	陈映泉, 钟勇. 心血管老化的机制、标志物和治疗[J]. 实用老年医学, 2024, 38(3): 299-303.
[5]	吴旭明, 柯先金, 孙波, 孙振杰. 应激性血糖升高比值联合糖化血红蛋白水平对老年急性缺血性脑卒中病人静脉溶栓后出血转化的预测价值[J]. 实用老年医学, 2024, 38(1): 54-58.
[6]	杨丹丹, 蒋琳芝, 李丽燕, 耿德勤, 李雷. 系统免疫炎症指数预测老年卒中病人溶栓后出血转化的价值[J]. 实用老年医学, 2023, 37(8): 789-793.
[7]	时铭蔚, 周朝娥, 王立娜, 孙春萍, 李君, 刘新民. 老年吸入性肺炎支气管肺泡灌洗液的生物学标志物和病原学分析[J]. 实用老年医学, 2023, 37(8): 794-797.
[8]	陈益升, 陈凤兰, 谢玉英, 肖兆祥, 宋峥宏, 秦洁行, 高丽. 老年缺血性脑卒中病人超急性期尿激酶静脉溶栓疗效的影响因素分析[J]. 实用老年医学, 2023, 37(4): 369-372.
[9]	田伟, 杨章超, 马文群, 李霞, 王景梅, 武一平. 超高龄急性缺血性脑卒中病人行可回收支架机械取栓的效果及安全性[J]. 实用老年医学, 2023, 37(4): 378-381.
[10]	易晓净, 郑开明, 王红胜, 赵义纯. NLR联合MPV预测老年急性缺血性脑卒中病人静脉溶栓治疗预后的临床价值[J]. 实用老年医学, 2023, 37(3): 274-277.
[11]	林巧茂, 李阔, 项宁, 王海燕. 血清可溶性髓系细胞触发受体-1与老年急性缺血性脑卒中严重程度及预后的关系[J]. 实用老年医学, 2022, 36(8): 827-832.
[12]	张美妮, 李敏, 薛佳婧, 杨谦, 王涛. 血清β2-微球蛋白联合脂蛋白相关磷脂酶A2与卒中后认知障碍的相关性研究[J]. 实用老年医学, 2022, 36(1): 23-26.
[13]	崔宇, 王晓坤, 张燕, 孙宏. 阿尔茨海默病病人血液、尿液的代谢组学研究[J]. 实用老年医学, 2021, 35(7): 692-695.
[14]	陈东丽, 宋丽云, 陈杰, 杨震, 郭敏. 依达拉奉对老年缺血性脑卒中半暗带体积及神经功能缺损程度的影响[J]. 实用老年医学, 2021, 35(6): 591-594.
[15]	胡航佳, 周轩, 胡发云, 简能日, 高荣慧. 高龄急性缺血性脑卒中病人行支架机械取栓治疗疗效及预后影响因素分析[J]. 实用老年医学, 2021, 35(5): 475-478.